189 related articles for article (PubMed ID: 22781545)
1. Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) for patients with advanced gastric cancer.
Xu Y; Zhao AG; Li ZY; Zhao G; Cai Y; Zhu XH; Cao ND; Yang JK; Zheng J; Gu Y; Han YY; Zhu YJ; Yang JZ; Gao F; Wang Q
Integr Cancer Ther; 2013 Sep; 12(5):414-22. PubMed ID: 22781545
[TBL] [Abstract][Full Text] [Related]
2. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of 272 patients with pancreatic cancer undergoing combined treatment.
Cao N; Zhao A; Zhao G; Wang X; Han B; Lin R; Zhao Y; Yang J
Integr Cancer Ther; 2015 Mar; 14(2):133-9. PubMed ID: 25567328
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of traditional chinese herbal medicine (a herbal formula for invigorating spleen) in gastric cancer patients with peritoneal metastasis.
Zhao L; Zhao AG; Zhao G; Xu Y; Zhu XH; Cao ND; Zheng J; Yang JK; Xu JH
Evid Based Complement Alternat Med; 2014; 2014():625493. PubMed ID: 24723961
[TBL] [Abstract][Full Text] [Related]
5. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of traditional Chinese herbal medicines against lung cancer.
Chen Y; Zhu J; Zhang W
Anticancer Drugs; 2014 Oct; 25(9):983-91. PubMed ID: 24892722
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
10. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer.
Sym SJ; Hong J; Jung M; Park J; Cho EK; Lee WK; Chung M; Kim HS; Lee JH; Shin DB
Cancer Chemother Pharmacol; 2012 Aug; 70(2):277-84. PubMed ID: 22752217
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation rs10484761 on 6p21.1 derived from a genome-wide association study is associated with gastric cancer survival in a Chinese population.
Kang M; Ding X; Xu M; Zhu H; Liu S; Wang M; Wu D; Tong N; Gong W; Zhou J; Zhang Z
Gene; 2014 Feb; 536(1):59-64. PubMed ID: 24325909
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
15. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
Zhou LY; Shan ZZ; You JL
Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
[TBL] [Abstract][Full Text] [Related]
16. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
17. [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].
Wang Y; Xu JM; Liu JZ; Lin L; Ge FJ; Li SS; Liu LJ; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):671-5. PubMed ID: 22340047
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
20. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
